Accine Dvelopment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The CEPI has partnered with an autonomous research institute of the Indian government and a Delhi-based biotech firm to develop vaccines that provide broad protection against SARS-Cov-2 variants and other beta coronaviruses.

Richard hatchettTranslational health scienceTechnology instituteDepartment of biotechnologyMinistry of scienceCoalition for epidemic preparedness innovationsMiddle eastEpidemic preparedness innovationsPanacea biotecSars cov 2 variantsEtacoronaviruses coronavirusesAccine dvelopmentAccine resarchVaccine funding